Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells

Abstract excerpt

// Karin Bauer 1, 2, 3 , Daniela Berger 1, 3 , Christoph C. Zielinski 3, 4 , Peter Valent 1, 2, 3 and Thomas W. Grunt 2, 3, 4 1 Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria 2 Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria 3 Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria 4 Department...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Myeloma Research and Treatments
• Share to Protein Degradation and Inhibitors
• Share to Ubiquitin and proteasome pathways